[go: up one dir, main page]

FI900219A0 - Nya diazoler. - Google Patents

Nya diazoler.

Info

Publication number
FI900219A0
FI900219A0 FI900219A FI900219A FI900219A0 FI 900219 A0 FI900219 A0 FI 900219A0 FI 900219 A FI900219 A FI 900219A FI 900219 A FI900219 A FI 900219A FI 900219 A0 FI900219 A0 FI 900219A0
Authority
FI
Finland
Prior art keywords
pct
date jan
diazoler
nya
sec
Prior art date
Application number
FI900219A
Other languages
English (en)
Finnish (fi)
Other versions
FI900219A7 (fi
Inventor
Joerg Senn-Bilfinger
Gerhard Grundler
Schaefer Hartmann
Kurt Klemm
Rainer Georg
Christian Schudt
Wolfgang Simon
Riedel Richard
Postius Stefan
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI900219A0 publication Critical patent/FI900219A0/fi
Publication of FI900219A7 publication Critical patent/FI900219A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
FI900219A 1987-07-16 1988-07-14 Uudet diatsolit FI900219A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH270987 1987-07-16
CH39088 1988-02-04
PCT/EP1988/000638 WO1989000570A1 (fr) 1987-07-16 1988-07-14 Nouveaux diazoles

Publications (2)

Publication Number Publication Date
FI900219A0 true FI900219A0 (fi) 1990-01-15
FI900219A7 FI900219A7 (fi) 1990-01-15

Family

ID=25684427

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900219A FI900219A7 (fi) 1987-07-16 1988-07-14 Uudet diatsolit

Country Status (19)

Country Link
US (1) US5112834A (fr)
EP (2) EP0370056A1 (fr)
JP (1) JP2656101B2 (fr)
KR (1) KR890701585A (fr)
CN (1) CN1031842A (fr)
AT (1) ATE145907T1 (fr)
AU (1) AU615666B2 (fr)
CA (1) CA1327796C (fr)
DE (1) DE3855692D1 (fr)
DK (1) DK12190A (fr)
FI (1) FI900219A7 (fr)
HU (1) HU204828B (fr)
IL (1) IL87118A (fr)
NO (1) NO900202L (fr)
NZ (1) NZ225417A (fr)
PH (1) PH24492A (fr)
PT (1) PT87988B (fr)
WO (1) WO1989000570A1 (fr)
ZW (1) ZW9788A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005136A1 (fr) * 1988-11-07 1990-05-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridines
EP0375819A1 (fr) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. Dérivés de 1,7'-[imidazo-[1,2-a]pyridin]5'-(6'H)ones
CN1046725C (zh) * 1994-06-20 1999-11-24 武田药品工业株式会社 稠合的咪唑化合物,它们的制备和应用
CZ290548B6 (cs) 1997-03-24 2002-08-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridinové deriváty a farmaceutický prostředek
US6436953B1 (en) 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PL375567A1 (en) * 2002-11-19 2005-11-28 Altana Pharma Ag 8-substituted imidazopyridines
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
BRPI0415209A (pt) 2003-10-08 2006-12-05 Schering Ag derivados de tetraidronaftaleno, processo para a produção deles e seu emprego como agentes antiinflamatórios
DE10347386B4 (de) * 2003-10-08 2006-05-24 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7662821B2 (en) * 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) * 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
RU2256452C1 (ru) * 2004-07-12 2005-07-20 Чередников Евгений Федорович Способ лечения синдрома меллори-вейсса
US20060084652A1 (en) * 2004-09-09 2006-04-20 Stefan Baeurle Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP1861074B1 (fr) * 2005-03-16 2013-04-24 Takeda GmbH Forme de dosage cachant le goût comprenant du roflumilaste
DE102005014089A1 (de) * 2005-03-22 2006-09-28 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US20060229305A1 (en) * 2005-03-22 2006-10-12 Markus Berger Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102005014090A1 (de) * 2005-03-22 2006-09-28 Schering Ag 5H-Benzocycloheptenderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
DE102006011352A1 (de) * 2005-03-23 2006-10-05 Unaxis International Trading Ltd. Verfahren zur Herstellung einer Drahtverbindung
US20070015761A1 (en) * 2005-04-14 2007-01-18 Anne Mengel Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102005017316A1 (de) * 2005-04-14 2006-10-19 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
WO2007026218A2 (fr) * 2005-09-01 2007-03-08 Pfizer Japan Inc. Derives de 2-alkyl imidazopyridine a substitution chromane
EP1834948A1 (fr) * 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Derives de tetrahydronaphtalene , procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires
EP2080513A1 (fr) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tétrahydropyridoéthers pour le traitement de la DMA
WO2015052256A1 (fr) 2013-10-08 2015-04-16 Katairo Gmbh Tétrahydropyridoéthers pour le traitement de la maladie de stargardt

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849576A (en) * 1964-01-29 1974-11-19 Oreal Process and cosmetic compositions for the treatment of skin and scalp
US3849396A (en) * 1973-01-08 1974-11-19 Upjohn Co Lincomycin and clindamycin 1-o-ethers
US3852279A (en) * 1973-03-12 1974-12-03 Squibb & Sons Inc 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines
GB1521471A (en) * 1974-06-05 1978-08-16 Randall & Son Ltd J Token-deposit locks
EP0024638A1 (fr) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Acides quinoléinone alkylcarboxyliques substitués, leur préparation et médicaments les contenant
DE3063144D1 (en) * 1979-09-07 1983-06-16 Byk Gulden Lomberg Chem Fab Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them
US4387219A (en) * 1979-11-13 1983-06-07 Sterling Drug Inc. 2-Hydroxy gentamicin compounds
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4430339A (en) * 1980-08-29 1984-02-07 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung Substituted oxiranecarboxylic acids, their preparation and their use as medicaments
US4409226A (en) * 1981-10-05 1983-10-11 Schering Corporation Imidazo[1,5-a]pyridines
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
SE8704248D0 (sv) * 1987-10-30 1987-10-30 Haessle Ab Medical use

Also Published As

Publication number Publication date
EP0299470A1 (fr) 1989-01-18
EP0370056A1 (fr) 1990-05-30
PT87988B (pt) 1995-05-04
PT87988A (pt) 1989-06-30
HU204828B (en) 1992-02-28
KR890701585A (ko) 1989-12-21
NO900202D0 (no) 1990-01-15
PH24492A (en) 1990-07-18
NO900202L (no) 1990-01-15
DK12190D0 (da) 1990-01-15
ZW9788A1 (en) 1988-11-16
IL87118A (en) 1993-01-31
CA1327796C (fr) 1994-03-15
JP2656101B2 (ja) 1997-09-24
US5112834A (en) 1992-05-12
EP0299470B1 (fr) 1996-12-04
JPH02504271A (ja) 1990-12-06
AU615666B2 (en) 1991-10-10
DE3855692D1 (de) 1997-01-16
HUT52097A (en) 1990-06-28
ATE145907T1 (de) 1996-12-15
FI900219A7 (fi) 1990-01-15
NZ225417A (en) 1991-08-27
DK12190A (da) 1990-01-15
CN1031842A (zh) 1989-03-22
WO1989000570A1 (fr) 1989-01-26
AU2126188A (en) 1989-02-13

Similar Documents

Publication Publication Date Title
FI900219A0 (fi) Nya diazoler.
FI862720A0 (fi) Nya pikolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande laekemedel.
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
FI853624A0 (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
FI862881L (fi) Munskoeljningsloesning.
NO855342L (no) Pyridoyrimidiner og fremgangsmaater for fremstilling derav.
FI880849A0 (fi) Nya siloxan-bis-maleimider och foerfarande foer deras framstaellning.
ES511097A0 (es) "procedimiento para la preparacion de derivados de oxindol".
FI884376A0 (fi) Nya mn (ii)-koordinationskompositioner vid fotografering med nmr.
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
GR3005520T3 (fr)
ATE92070T1 (de) Azachromanderivate.
FI882444A0 (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
FI821141L (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
SE8002937L (sv) Nytt n,n'-difenylhydrazinderivat och forfarande for framstellning derav
ATE124794T1 (de) Fotografische beta-ketoamide und fotografische elemente, die diese amide enthalten.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
FI934252A0 (fi) 1,5,6,7-tetrahydro-4h-indazol-4-oner innehaollande laekemedel, nya 1,5,6,7-tetrahydro-4h-indazol-4-oner och foerfarande foer deras framstaellning
KR920018470U (ko) 공냉식 냉각기의 난류형성기(Turbulator)
RO85608A2 (fr) Composition d'email thermoresistant

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH